On April 10, 2018, Mr. Ken Berlin notified the Board of Rosetta Genomics Ltd. that he is resigning as President and CEO of the company, effective April 18, 2018, to pursue other opportunities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -.--% |
2018 | Genoptix, Inc. cancelled the acquisition of Rosetta Genomics Ltd.. | CI |
2018 | Rosetta Genomics Ltd.(NasdaqCM:ROSG) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 592 | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ROSGQ Stock
- News Rosetta Genomics Ltd.
- Rosetta Genomics Ltd. Announces Resignation of Ken Berlin as President and CEO, Effective April 18, 2018